Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria.
Gericke J, Metz M, Ohanyan T, Weller K, Altrichter S, Skov PS, Falkencrone S, Brand J, Kromminga A, Hawro T, Church MK, Maurer M.
Gericke J, et al. Among authors: falkencrone s.
J Allergy Clin Immunol. 2017 Mar;139(3):1059-1061.e1. doi: 10.1016/j.jaci.2016.07.047. Epub 2016 Nov 9.
J Allergy Clin Immunol. 2017.
PMID: 27838346
No abstract available.